- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG-BMA-MAN.2: 9 residues within 4Å:- Chain A: N.119
- Chain D: D.249, Q.310, V.311, N.312, R.313, Y.372, G.373, T.374
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:N.312, D:N.312, D:R.313, D:N.312, D:R.313, D:D.249
- Water bridges: D:Y.372, D:Y.372, D:Q.310, D:R.283, D:Q.310, D:Q.310, D:R.313
NAG-NAG-BMA-MAN.4: 8 residues within 4Å:- Chain A: Q.310, V.311, N.312, R.313, Y.372, G.373, T.374
- Chain B: N.119
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:N.312, A:N.312, A:R.313, A:N.312, A:R.313
- Water bridges: A:Y.372, A:Y.372, A:Q.310, A:Q.310, A:D.249, A:R.283, A:E.294, A:Q.310, A:Q.310, A:R.313, A:R.313
NAG-NAG-BMA-MAN.10: 9 residues within 4Å:- Chain B: D.249, Q.310, V.311, N.312, R.313, Y.372, G.373, T.374
- Chain C: N.119
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:N.312, B:N.312, B:R.313, B:N.312, B:R.313, B:D.249, B:D.249
- Water bridges: B:Y.372, B:Q.310, B:R.283, B:Q.310, B:Q.310, B:R.313
NAG-NAG-BMA-MAN.12: 8 residues within 4Å:- Chain C: Q.310, V.311, N.312, R.313, Y.372, G.373, T.374
- Chain D: N.119
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:N.312, C:N.312, C:R.313, C:N.312, C:R.313
- Water bridges: C:Y.372, C:Q.310, C:Q.310, C:D.249, C:R.283, C:E.294, C:Q.310, C:Q.310, C:R.313, C:R.313
- 4 x CA: CALCIUM ION(Non-covalent)
CA.5: 5 residues within 4Å:- Chain A: D.212, G.216, D.243, G.264, Q.266
6 PLIP interactions:5 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.212, A:G.216, A:D.243, A:G.264, A:Q.266, H2O.1
CA.7: 5 residues within 4Å:- Chain B: D.212, G.216, D.243, G.264, Q.266
6 PLIP interactions:5 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.212, B:G.216, B:D.243, B:G.264, B:Q.266, H2O.19
CA.13: 5 residues within 4Å:- Chain C: D.212, G.216, D.243, G.264, Q.266
6 PLIP interactions:5 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.212, C:G.216, C:D.243, C:G.264, C:Q.266, H2O.36
CA.15: 5 residues within 4Å:- Chain D: D.212, G.216, D.243, G.264, Q.266
6 PLIP interactions:5 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.212, D:G.216, D:D.243, D:G.264, D:Q.266, H2O.54
- 4 x FSI: 5-acetamido-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid(Post Translational Modification)
FSI.6: 13 residues within 4Å:- Chain A: R.37, E.38, R.71, W.97, I.141, R.143, A.165, E.195, E.196, R.211, N.213, R.290, Y.325
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:W.97, A:I.141, A:R.143
- Hydrogen bonds: A:E.38, A:R.71, A:R.143, A:E.196, A:R.211
- Water bridges: A:R.75, A:E.146, A:E.196, A:E.196, A:E.196, A:R.211, A:R.211, A:R.290
- Salt bridges: A:R.37, A:R.211, A:R.290
FSI.8: 13 residues within 4Å:- Chain B: R.37, E.38, R.71, W.97, I.141, R.143, A.165, E.195, E.196, R.211, N.213, R.290, Y.325
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:W.97, B:I.141, B:R.143
- Hydrogen bonds: B:E.38, B:R.71, B:R.143, B:E.196, B:R.211, B:R.211
- Water bridges: B:R.75, B:E.146, B:E.196, B:R.290
- Salt bridges: B:R.37, B:R.211, B:R.290
FSI.14: 13 residues within 4Å:- Chain C: R.37, E.38, R.71, W.97, I.141, R.143, A.165, E.195, E.196, R.211, N.213, R.290, Y.325
18 PLIP interactions:18 interactions with chain C- Hydrophobic interactions: C:W.97, C:I.141, C:R.143
- Hydrogen bonds: C:E.38, C:R.71, C:R.143, C:E.196, C:R.211
- Water bridges: C:R.75, C:E.146, C:E.196, C:E.196, C:R.211, C:R.211, C:R.290
- Salt bridges: C:R.37, C:R.211, C:R.290
FSI.16: 13 residues within 4Å:- Chain D: R.37, E.38, R.71, W.97, I.141, R.143, A.165, E.195, E.196, R.211, N.213, R.290, Y.325
16 PLIP interactions:16 interactions with chain D- Hydrophobic interactions: D:W.97, D:I.141, D:R.143
- Hydrogen bonds: D:E.38, D:R.71, D:R.143, D:E.196, D:R.211, D:R.211
- Water bridges: D:R.75, D:E.146, D:E.196, D:E.196
- Salt bridges: D:R.37, D:R.211, D:R.290
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vavricka, C.J. et al., Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors. Nat Commun (2013)
- Release Date
- 2013-02-20
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x FSI: 5-acetamido-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vavricka, C.J. et al., Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors. Nat Commun (2013)
- Release Date
- 2013-02-20
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B